A
Abha Mishra
Researcher at Indian Institutes of Technology
Publications - 35
Citations - 729
Abha Mishra is an academic researcher from Indian Institutes of Technology. The author has contributed to research in topics: Fermentation & Gallic acid. The author has an hindex of 11, co-authored 35 publications receiving 517 citations. Previous affiliations of Abha Mishra include Indian Institute of Technology (BHU) Varanasi & Banaras Hindu University.
Papers
More filters
Journal ArticleDOI
Gallic acid: Molecular rival of cancer
TL;DR: The data so far available, both from in vivo and in vitro studies, indicate that this dietary polyphenol could be a promising agent in the field of cancer chemoprevention.
Journal ArticleDOI
Production of L-asparaginase, an anticancer agent, from Aspergillus niger using agricultural waste in solid state fermentation.
TL;DR: The study suggests that choosing an appropriate substrate when coupled with process level optimization improves enzyme production markedly and developing an asparaginase production process based on bran of G. max as a substrate in SSF is economically attractive as it is a cheap and readily available raw material in agriculture-based countries.
Journal ArticleDOI
Nanotechnology in Enzyme Immobilization: An Overview on Enzyme Immobilization with Nanoparticle Matrix
TL;DR: This review mainly focuses on the current status of enzyme immobilization using nanocarriers, nanoparticles or polymeric matrix materials, which aim to summarize the latest research on the natural polymer, chitosan based nanoparticles in various enzyme immobilizations.
Journal ArticleDOI
Dual inhibition of chaperoning process by taxifolin: Molecular dynamics simulation study
TL;DR: Taxifolin was found to act as an inhibitor of chaperoning process and may play a potential role in the cancer chemotherapeutics.
Book ChapterDOI
Antiviral and Antimicrobial Potentiality of Nano Drugs
TL;DR: This chapter discusses the antimicrobial activities of numerous nanoparticles such as carbon-based nanoparticles like carbon nanotubes, fullerenes, graphene oxides, and metallic nanoparticles together with polymeric chitosan nanoparticles as an antimicrobial agent, their mode of action, nanoparticle effect on drug-resistant bacteria, and the risks attendant with their use as antimicrobial agents to tissues of human cells.